About ACHORD
The Alliance for Canadian Health Outcomes Research in Diabetes (ACHORD) is an emerging team in diabetes research, in Canada and internationally. ACHORD Investigators and collaborators have been involved individually and in collaboration in various sectors of health research, namely the clinical, health services and population health sectors.
ACHORD is based at the University of Alberta, School of Public Health, Department of Public Health Sciences in Edmonton, Alberta, Canada.
Recent Publications
-
Determinants of lifestyle behavior in type 2 diabetes: results of the 2011 cross-sectional survey on living with chronic diseases in Canada.
-
Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study.
-
Anthropometric and dietary predictors of insulin sensitivity in 10- to 14-year-old boys and girls.
-
Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study.
-
Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies.
-
Comparative Safety and Effectiveness of Metformin in Patients with Diabetes and Heart Failure: Systematic Review of Observational Studies Involving 34000 Patients.
-
Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure data.
-
Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial.
WHAT'S NEW
-
Congratulations Robin Lau!
Congratulations to Robin Lau who successfully completed his PhD Candidacy Exam on Wednesday, May 15, 2013. Way to go Robin!
-
Congratulations Ahmed Abdelmoneim!
Congratulations to Ahmed Abdelmoneim for receiving a Graduate Student Teaching Award, the Andrew Stewart Memorial Graduate Prize, and the Izaak Walton Killam Memorial Scholarship, all awarded by the University of Alberta. Ahmed also received a scholarship from the International Society for Pharmacoepidemiology. Well done!
Newsletters
